BASF licenses CRISPR-Cpf1 from the Broad Institute of MIT and Harvard

(BASF SE) BASF has attained a global, non-exclusive licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 genome editing technology to improve products in agricultural and industrial microbiology applications.
Source: EurekAlert! - Biology - Category: Biology Source Type: news